Open access peer-reviewed chapter

Exploring Surface Display Technology for Enhancement of Delivering Viable Lactic Acid Bacteria to Gastrointestinal Tract

Written By

Shirin Tarahomjoo

Submitted: November 16th, 2011 Reviewed: June 18th, 2012 Published: January 30th, 2013

DOI: 10.5772/50783

Chapter metrics overview

2,484 Chapter Downloads

View Full Metrics

1. Introduction

Anchoring of proteins to the cell surface is a common theme in nature and the processes governed by different surface proteins are bases of many biological phenomena, such as cell-cell recognition, signal transduction, adherence, colonization, and immunoreactions (Westerlund & Korohonen, 1993). The utilization of cellular surface anchoring systems for the display of heterologous proteins on the surface of microbial cells has been developed into an active research area that holds a great promise for a variety of biotechnological applications including the production of whole cell biocatalysts, microbial adsorbents, live vaccines, antibody fragments, and screening of novel proteins (Hansson et al., 2001; Kondo& Ueda, 2004; Lee et al., 2003). Generally construction of these systems is accomplished by the expression of heterologous peptides or proteins as fusions with anchoring domains, which are able to attach to the cell surface (Fig 1.). Anchoring domains are usually cell surface proteins or their fragments. Depending on the characteristics of target and anchor proteins, N-terminal fusion, C-terminal fusion or sandwich fusion strategy can be considered (Lee et al., 2003).

Figure 1.

Schematic representation of a microbial surface display system

LAB are gram positive, non-spore forming, fastidious, acid tolerant, and strictly fermentative that secret lactic acid as the major end product of sugar fermentations (Axelsson, 1998). LAB are naturally present in media rich in organic nutrients such as food products and digestive tracts. They are a genetically diverse group of bacteria with GC contents varying from 34 to 53%, including rod shaped bacteria such as lactobacilli and also cocci such as lactococci, enterococci, pediococci, and leuconostoc (Stiles & Holzapfel, 1997). Since time immemorial, LAB have been used for the fermentation and preservation of food products, particularly dairy products, fermented meats, and vegetables. Consequently, several strains of LAB have a long record of safe association with humans and human foodstuffs (Mckay & Baldwin, 1990). The display of proteins on the surface of LAB cells can broaden or improve applications of these bacteria. In this chapter, we intend to describe cell surface anchoring domains used in LAB surface display systems. Then applications of surface engineered LAB are depicted and key factors affecting their performances are highlighted. Moreover, we explained comprehensively a novel application of the protein display in LAB, which is potentially useful for enhancement of the delivery of viable LAB to the gastrointestinal tract (GIT).


2. Anchoring domains in surface display systems of LAB

The cell surface anchoring domains utilized for the development of LAB surface display systems are associated with the cell surface either covalently or noncovalently. Depending on the applied anchoring domains, two modes of the protein display can be considered, including internal and external mode of the protein display. In the case of the internal mode of protein display, fusions of target proteins to anchoring domains are expressed in LAB cells, and therefore target proteins are displayed on the surface of expression hosts, whereas in the case of the external mode of protein display, expression and display hosts are different from each other. If the association of anchoring domains with the cell surface is of a non covalent nature, they can bind to cells when they are added from the outside. Therefore, fusions of target proteins to anchoring domains are produced in suitable expression hosts capable of their correct folding and modifications. The fusion proteins are then purified and incubated with desired display hosts in order to attach to the cell surface. As a result, the external mode of protein display can retain the nongenetically modified status of cells and is valuable for food and vaccine development.

The surface display systems based on the internal mode of protein display are often associated with the limitations in terms of the translocation of target proteins to the cell surface and the control of surface intensity of target proteins. The mislocalization of target proteins can affect their functions negatively( Dieye et al., 2003; Van Der Vaart et al., 1997; Wan et al., 2002). In contrast, the surface display systems based on the external mode of protein display can ensure the full exposure of target proteins outside of the cell wall and the surface intensity of target proteins can readily be adjusted by selecting appropriate display hosts and suitable concentrations for the fusion proteins in the incubation mixture. However, regarding noncovalent interaction of target proteins with the cell surface, the possibility of dissociation of target proteins from the cell surface should be considered.

2.1. Covalent anchors

2.1.1. LPXTG motif containing anchors

The most widely used surface display systems of LAB are based on cell wall anchored proteins that contain an LPXTG motif. These proteins are first synthesized as a preprotein containing an N-terminal signal peptide and a C-terminal cell wall anchor domain. The anchor domain starts at its C-terminus with a short tail of positively charged residues (five to seven amino acids) that remain in the cytoplasm. Upstream of the cytoplasmic domain, a stretch of approximately 30 hydrophobic amino acids is preceded by the highly conserved pentapeptide LPXTG. The charged tail and hydrophobic domain are thought to function as a temporary stop to position the LPXTG motif for proteolytic cleavage. Correct positioning results in cleavage between the threonine and glycine residues followed by amid linkage of the threonine residue to the peptide crossbridge in the peptidoglycan of cell wall, by the action of a sortase (Navarre & Schneewind, 1994). The amino acid composition of the peptide crossbridge varies among the different LAB species and is flexible with respect to the sorting reaction (Strauss et al., 1998; Ton-That et al., 1998). The anchor domain is preceded by a wall associated region of about 50 to 125 residues and is characterized by a high percentage of proline/glycine and/or threonine/serine residues (Fischetti et al., 1990). In surface display genetic constructs, secretion signal peptides are fused to the N-termini of target proteins to transport them to the outside of cell and the LPXTG motif containing anchors are fused to the C-termini of target proteins in order to attach them to the cell surface. The cell surface associated proteinases of Lactococcus lactisand Lactobacilli casei(PrtPs), M6 protein of Streptococcus pyogenes, and Protein A of Staphylococcus aureus(SpA) are among LPXTG type anchors, which have mainly been used for the construction of surface display systems in LAB (Maassen et al., 1999; Norton et al., 1996; Piard et al., 1997; Pouwels et al., 1996; Steidler et al., 1998).

Slight deviations from the LPXTG consensus sequence is found in some LAB. Recently Kleerebezem (2003) found that sortase substrates of Lactobacillus plantarumcontain LPQTXE motifs instead of the LPXTG motifs. In addition, in the carboxy end of cell surface proteinase of Lactobacillus delbrueckii(PrtB), a degenerated LPKKT motif is surrounded by two imperfect repeats of 59 residues, which are lysine rich. However, downstream of the LPKKT motif, there is no hydrophobic domain and no charged tail at the extreme C-terminus. It was shown that the C-terminal region of PrtB was able to attach to the cell wall of L. lactisand the capacity of attachment was drastically reduced by absence of the duplicated sequences. The high content of total positive charges in the anchoring region of PrtB suggests interactions of the anchor with the negatively charged teichoic acids of the cell wall. The mechanism of PrtB attachment to the cell wall probably implicates electrostatic forces (Germond et al., 2003).

2.1.2. Lipoprotein anchors

Lipoproteins are lipid modified proteins produced as secretory precursors with a signal peptide linked to their amino termini. The C-terminal region of their signal peptide contains a well conserved lipobox motif of four amino acid residues and invariably, the last residue is cysteine. The covalent binding of lipoproteins to the cell membrane is generally achieved via diacylglyceryl modification of the indispensible cysteine residue in the lipobox by a diacylglyceryl transferase. Lipidation of the cysteine residue is a perquisite for cleavage of the signal peptide by a lipoprotein specific signal peptidase (SPase II)(Yamaguchi et al., 1988; Venema et al., 2003). The lipoprotein anchors should be fused at their C-termini to N-termini of target proteins in order to display them on the cell surface. Poquet (1998) identified four lactococcal lipoprotein anchors using nuclease of S. aureusas an export specific reporter enzyme. The nuclease activity was shown to require an extracellular location in L. Lactisdemonstrating its suitability to report the protein export. The enzyme activity was detected in a plate test by the presence of pink halos. Fusions of the lipoprotein anchors to the nuclease expressed in L. Lactiswere associated with the cell fraction and the recombinant lactococcal cells showed strong nuclease activities indicating the cell surface anchoring function of the lipoproteins. For one of the anchors (NlpI), the surface location of the fusion protein was also confirmed by proteinase K treatment of L. lactiscells (Poquet et al., 1998). Basic membrane protein A (BmpA) of L. Lactisis a putative lipoprotein that has been used for the protein display on the surface of lactococci (Berlec et al., 2011).

2.1.3. Transmembrane anchors

The strategy to insert target amino acid sequences in the exterior loop between transmembrane spanning domains (TMSs) can limit the insert size in order not to disturb the membrane protein topology. Therefore, a fusion approach is often preferred in which a target protein is simply linked at its N-terminus to one or more TMSs of a cytoplasmic membrane protein. L. Lactisbacteriocin transport accessory protein (LcnD) and Bacillus subtilispoly-γ-glutamate synthetase A protein (PgsA) are transmembrane proteins, which were fused to the N-termini of target proteins in order to display them on the cell surface of L. Lactisand L. casei, respectively (Franke et al., 1996; Narita et al., 2006). In addition, in the same random procedure as described above for the lipoprotein anchors Poquet (1998) identified seven lactococcal gene fragments encoding TMSs that function as membrane anchors in L. Lactis.

2.2. Noncovalent anchors

2.2.1. S- layer protein anchors

Some LAB strains possess a surface layer (S-layer) of proteins as the outermost structure of the cell envelope. These S-layers are composed of regularly arranged subunits of a single protein (SLP) and may constitute up to 20% of the total cell protein content. S-layers self assemble in entropy driven process during which multiple noncovalent interactions between individual SLPs and the underlying cell surface take place. These two types of interactions in SLPs can be assigned to two separate domains including the self assembly domain and the cell wall binding domain. These domains have been characterized in SLPs of Lactobacillus acidophilusATCC 4356 (SA), Lactobacillus crispatusJCM 5810 (CbsA), and Lactobacillus brevisATCC 8287 (SlpA). The C-terminal regions of SA and CbsA showed the cell surface anchoring function and the N-terminal regions were involved in the self assembly process. In contrast, the self assembly domain of SlpA was located in the C-terminal region and its cell wall binding domain was found in the N-terminal region. The (lipo)teichoic acids were identified as the cell wall ligands of SA and CbsA. Moreover, the specific cell wall component that interacts with SlpA was shown to be the neutral polysaccharide moiety of the cell wall (Antikainen et al., 2002; Avall-Jaaskelainen et al., 2008; Smit et al., 2002). Avall-Jaaskelainen (2002) decribed the construction of recombinant L. brevisstrains expressing poliovirus epitope VP1 of 10 amino acid residues inserted in the slpAgene. Insertion sites in the slpAgene were selected on the basis of the hydrophilicity profile of the SlpA protein. The four most hydrophilic parts of the SlpA protein were selected for testing because it was expected that parts of them were likely to be sites where the epitope would be accessible to the cell surface. One of the insertion sites was at the N- terminus of SlpA and the others were at its C-terminus. Only one site at the C-terminus showed strong colour response in whole cell enzyme linked immunosorbent assay (ELISA) using anti epitope antibody demonstrating that the epitope was accessible on the surface of the recombinant L. brevis. In another study, the C-terminal region of SLP of L. crispatusK2-4-3 (LcsB) isolated from the chicken intestine was used for the construction of surface display systems. Green fluorescent protein (GFP) was fused to the N-terminus of LcsB. The fusion protein (GFP-LcsB) was expressed in Escherichia coli.It was then purified and mixed with various LAB. The binding of the fusion protein to LAB cells was viewed by the fluorescence microscopy. GFP-LcsB was associated with the cell surface of various LAB including L. delbrueckii, L. brevis, Lactobacillus helveticus, Lactobacillus johnsonii, L. crispatus, Streptococcus thermophilus, L. lactisand Lactobacillus salivarius. GFP alone did not bind to the cells. These results indicated that binding of GFP to the surface of LAB cells is directed by LcsB. However, the fusion protein could not attach to the cell surface of L. casei. The reason for this observation requires further studies to elucidate the target ligand of LcsB on the cell surface of LAB (Hu et al., 2011).

2.2.2. Lysin motif containing anchors

The lysine motif (LysM) was first discovered in the lysozyme of Bacillusphage ø29 as a C-terminal repeat composed of 44 amino acids separated by 7 amino acids. The cell wall attachment of several bacterial proteins in both gram positive and gram negative organisms occurs through LysMs, often repeated several times in the protein sequence. Many LysM containing proteins are cell wall hydrolases (Buist et al., 2008). The C-terminal region of peptidoglycan hydrolase (AcmA) of L. lactisMG 1363 (CpH) contains three 44 amino acid residue lysMs separated by stretches of 21 to 31 amino acids rich in the serine, threonine, and asparagine residues. CpH is able to bind to the cell surface of lactococci and several strains of lactobacilli. Moreover, CpH is able to bind both to the cell surface of LAB treated with sodium dodecyl sulfate (SDS) to remove cell wall associated proteins and LAB treated with trichloroacetic acid (TCA) to remove carbohydrates and (lipo) teichoic acids. These findings suggest that peptidoglycan is the binding ligand of the CpH domain (Buist et al., 1995). The C-terminus of endolysin Lyb5 of Lactobacillus fermentumbacteriophage øPYB5 (Ly5C) contains three LysMs. Each of LysMs is composed of 41 amino acids and they are separated by intervening sequences varying in length and composition. Ly5C fused to GFP was expressed in E. coli. After mixing the fusion protein with various cells in vitro, GFP was successfully displayed on the surfaces of L. lactis, L. casei, L. brevis, L. plantarum, L. fermentum, L. delbrueckii, L. helveticus, and S. thermophiluscells. Increases in the fluorescence intensities of TCA treated L. lactisand L. caseicells compared to those of nontreated cells showed that the cell wall peptidoglycan was the cell surface binding target of Ly5C. Concentration of sodium chloride and pH influenced the binding capacity of the fusion protein, and optimal conditions of these factors were determined empirically in order to obtain high fluorescence intensities of L. lactisand L. caseicells (Hu et al., 2010). N-terminus of putative muropeptidase (MurO) of L. plantarumalso contains two LysMs composed of about 43 amino acids separated by 22 amino acid residue sequences. The LysM domain fused to GFP was expressed in E. coliand it was able to bind to the cell surface of L. plantarumafter being mixed with the cells (Xu et al., 2011). Examination of supernatant fractions from broth cultures of L. fermentum, revealed the presence of a 27-kDa protein termed Sep. The N-terminus of Sep contains a LysM. Sep fused N-terminally to a six histidine epitope was expressed in L. fermentum, Lactobacillus rhamnosus,and L. lactis. The protein was found associated with the surface of the expression hosts. However, it was largely present in the supernatant of the cell cultures (Turner et al., 2004).

2.2.3. WxL anchors

The C-terminal cell wall binding domain designated WxL was first identified in proteins of Lactobacillusand other LAB based on in silicoanalysis (Kleerebezem et al., 2010). WxL domain contains a WxL motif followed by a proximal well conserved YXXX(L/I/V)TWXLXXXP motif. This domain was found in gene clusters that also encode additional extracellular proteins with C-terminal membrane anchors and LPxTG motif containing anchors, suggesting that they form an extracellular protein complex (Siezen et al., 2006). The C-terminal WxL domains identified in two proteins of Enterococcus faecaliswere fused at their N-termini to an export reporter enzyme (nuclease of S. aureus)and a secretion signal peptide. The fusion proteins expressed in E. faecaliswere detected in both cell wall and supernatant fractions of the recombinant enterococci. Removal of the WxL domains from the fusion proteins nearly eliminated them in the cell wall. Treatment of the cell wall fractions with SDS disrupted binding of the fusion proteins to these fractions. These results indicated that the fusion proteins had noncovalent interactions with the cell wall of E. faecalis. The fusion proteins were able to attach to the cell surface of E. faecalisand L. johnsoniiwhen they were added exogenously (Brinster et al., 2007).

2.2.4. Other anchors

Basic surface protein A (BspA) is a surface located protein of L. fermentumBR11. Sequence comparisons have been shown that BspA is a member of family III of the solute binding proteins. Most solute binding proteins are lipoproteins. However, BspA is not a lipoprotein and is attached to the cell envelope by electrostatic interactions. It has been used as a fusion partner to direct proteins to the cell surface of L. fermentumBR11. In these constructs, BspA was fused at its C-terminus to target proteins and the fusion proteins were expressed in L. fermentumBR11 (Turner & Giffard, 1999). The C-terminal region of cell associated dextransucrase of Leuconostoc mesentroidesIBT-PQ (DsrP) contains five repeats of 65 amino acid residues. The domain expressed in E. coliwas able to bind to the cell surface of L.mesentroidesIBT-PQ cells after being mixed with the cells (Olvera et al., 2007). The carboxy end of PrtP of Lactobacillus acidophiluswas used for the protein display on L. acidophilususing the internal mode. The association of this domain with the cell surface was mediated by electrostatic interactions (Kajikawa et al., 2011).


3. Applications of surface engineering of LAB

Research in the field of surface engineering of LAB has mainly been focused on the construction of vaccine delivery vehicles but other interesting applications have also been reported. In this section, we will describe different areas of biotechnology in which surface display of heterologous proteins on LAB have been investigated.

3.1. Development of vaccine delivery vehicles

Vaccination represents one of the most effective public health strategies to combat infectious diseases (Mielcarek et al., 2001). One of the technologies being developed for vaccine production is the use of bacteria as live vectors for the delivery of recombinant vaccine antigens to the immune system. Such vaccines have the potential for the production of protective antigens in vivoand are inexpensive to manufacture (Moore et al., 2001).

Most infections affect or initiate infectious processes at mucosal surfaces and mucosal local immune responses can block pathogens at the portal of entry. Live bacterial vaccines can induce mucosal, as well as systemic, immune responses when delivered via mucosal routes, such as oral or intranasal administration (Mielcarek et al., 2001). The mucosal, needle free, administration of vaccines can significantly decrease the need for syringes with their inherent added cost and risk of disease transmission, and it can increase compliance, and consequently the coverage of vaccination programs (Giudice & Campbell, 2006). The first live recombinant bacterial vectors developed were derived from attenuated pathogenic microorganisms. In addition to the difficulties often encountered in the construction of stable attenuated mutants of pathogenic organisms, attenuated pathogens may retain a residual virulence level that renders them unsuitable for the vaccination of partially immunocompetent individuals such as infants, the elderly or immunocompromised patients (Curtiss, 2002). These problems can be addressed by the application of nonpathogenic food grade LAB as antigen delivery vehicles. LAB therefore represent attractive alternatives as antigen carriers and their use has mainly been focused on the construction of mucosal vaccines. The cellular location of antigens can influence the elicited immunological responses. Cell surface anchored antigens are better recognized by the immune system than those produced intracellularly. Furthermore, intracellular production of antigens may limit their in vivorelease. The vaccines constructed by the cell surface anchoring of antigens are of particulate nature. In contrast to most soluble antigens, which are ignored by the immune systems, particles are recognized as foreign and as danger eliciting effective immune responses (Storni et al., 2005). Tetanus toxin fragment C (TTFC) is an immunogen protective against tetanus. In a pioneer study by Norton (1996) three recombinant strains of L. lactisexpressing TTFC in three cellular locations, intracellular, secreted or cell surface anchored via lactococcal PrtP were constructed. The recombinant lactococcal cells were used to immunize mice, which were then challenged by the subcutaneous inoculation of tetanus toxin. When compared in terms of the dose of expressed TTFC required to elicit protection against the lethal challenge, the cell surface displayed form of TTFC was significantly (10-20 fold) more immunogenic than the alternative forms of the protein. The result of this study indicated the advantage of antigen display on the cell surface for the construction of the lactococcal vaccines. In addition to TTFC, several other antigens were displayed on the surface of LAB and the protection studies were carried out to evaluate the efficiency of these vaccines (Bermudez-Humaran et al., 2005; Hou et al., 2007; Kajikawa et al., 2007; Lee & Faubert, 2006; Lee et al., 2006; Li etal., 2010; Lindholm et al., 2004; Liu et al., 2009; Medina et al., 2008; Poo et al., 2006; Tang & Li, 2009; Wei et al., 2010; Xin et al., 2003).

F18 fimbrial E. colistrains are associated with porcine postweaning diarrhea and pig edema disease. Adherence of F18 fimbrial E. colito porcine intestinal epithelial cells is mediated by the FedF adhesin of F18 fimbriae. For the development of a mucosal vaccine against porcine postweaning diarrhea and edema disease, different expression cassettes for the display of FedF on the cell surface of L. lactiswere constructed. Preliminary attempts to express the entire FedF protein as a fusion protein in L. lactisresulted in inefficient secretion and degradation of the adhesin. Therefore, only those regions of FedF required for binding specificity to porcine intestinal epithelial cells, were used in the construction of cell surface display systems. Initially, recombinant L. lactisclones secreting the partially overlapping receptor binding domains of FedF (42 and 62 amino acid residues) were prepared using two different signal peptides. Substantially higher levels of the fusion proteins (four- to six-fold) were secreted by the clones possessing L. brevisSlpA signal peptide than by those possessing L. lactisUsp45 signal peptide. In order to enhance the secretion of the fusion proteins, a synthetic sequence encoding the propeptide LEISSTCDA was inserted between the signal sequences and the receptor binding domains of FedF. For the construction of surface display systems, the secreted proteins were anchored to the cell wall of L. lactisvia the CpH protein or the lactococcal PrtP protein. Three groups of expression vectors with prtPspacer sequences of 0.6, 0.8 and 1.5 kb were also designed. The spacers inserted between the receptor binding domains and the anchors. Whole cell ELISA for the detection of cell surface exposure of the FedF receptor binding regions showed that the CpH anchor performed significantly better than the PrtP anchor, particularly in a L. lactismutant devoid of the extracellular housekeeping protease, HtrA. Among the cell surface display systems possessing the CpH anchor, only those with the longest PrtP spacer resulted in efficient binding of the recombinant L. lactiscells to porcine intestinal epithelial cells (Lindholm et al., 2004).

In another study, pneumococcal surface antigen A (PsaA), a conserved membrane anchored virulence factor, was expressed in different strains of LAB and it was associated with the surface of LAB cells. L. plantarumand L. helveticuswere found to be more effective at inducing mucosal and systemic anti-PsaA immune responses than L. caseifollowing intranasal vaccination of mice. Because all three Lactobacillusstrains expressed almost the same amount of PsaA and were also recovered from mice nasal mucosa in the same period (3 days), the observed differences among their respective antibody responses may reflect their different intrinsic adjuvant properties. PsaA expressed by L. lactisat 2×10-8 ng/ colony forming unit (CFU), which was about 10% of PsaA amount produced by the Lactobacillusstrains. The recombinant L. lactisremained in the nasal mucosa only 1 day after the inoculation. Therefore, the inability of L. lactisexpressing PsaA to significantly induce serum IgG or secreted IgA in mice can be explained by the low level of antigen production in this bacterium compared with the Lactobacillusstrains and also its shorter persistence in the nasal mucosa. Intranasal inoculation of the mice with L. lactisexpressing PsaA did not exert any effect on Streptococcus pneumoniaerecovery from the nasal mucosa upon colonization challenge, in comparison with inoculation of saline or the control L. lactiscarrying the expression vector devoid of the antigen gene. On the other hand, all the recombinant Lactobacillusstrains showed a significant reduction of S. pneumoniaecolonization when compared with the saline group (100.6-101.35 CFU). However, only L. helveticusexpressing PsaA showed a significant reduction of S. pneumoniaecolonization in relation to control L. helveticus(10 CFU) (Oliviera et al., 2006). Among LAB, L. lactisand Lactobacillusstrains have mostly been used for the construction of LAB vaccines. Selection of LAB strains for use as antigen carriers depends on their persistence in the host, capacity to express foreign antigens, and intrinsic adjuvanticity. L. lactisdoes not colonize the internal cavities of man or animals. Therefore, the use of lactobacilli, which are able to colonize the cavities such as the GIT transiently seems more advantages than that of L. lactisfor developing LAB vaccines because the longer persistence of lactobacilli in the host body may enhance immunological responses. On the other hand, the progress in the genetics of lactobacilli is more recent than that of lactococci. Furthermore, the availability of a commercial powerful gene expression system for L. lactis, nisin inducible gene expression system, urged many researchers to establish LAB vaccines based on lactococci. It has been reported that several LAB strains particularly strains from the genera Lactobacillusare able to act as adjuvants. This aspect should be considered when selecting a vaccine strain as it is a natural way to potentiate the immune reaction against heterologous antigens produced by recombinant LAB. It might be speculated that a high level of the antigen expression will not be necessary when using immunostimulatory LAB strains. However, studies have not yet been reported for comparison of the adjuvanticity of L. lactisand different lactobacilli. L. caseiand L. plantarumare among Lactobacillusstrains, which can colonize the GIT of human and mice and they show immunostimulatory properties (Pouwels et al., 1998; Wells et al., 1996).

It has been reported that the flagellin of Salmonellahas significant vaccine potential because it is the only surface antigen of Salmonelladetected to have a mitogenic stimulatory effect on lymphocytes (Toyota-Hantani et al., 2008). Bacterial flagellins can also induce innate immune responses through their interaction with Toll-like receptor 5 (TLR5) (Ramos et al., 2004). Recombinant L. caseicells expressing the flagellin of SalmonellaEnteritidis (LCF) on their cell surface via L. caseiPrtP anchor were constructed. Intragastric immunization of mice with the recombinant lactobacilli resulted in a significant level of protective immunity against an oral challenge with S.Enteritidis. There was no significant difference in the level of protection after immunization with the recombinant lactobacilli compared with the free flagellin isolated from S. Enteritidis, although the amount of flagellin carried by LCF was less than that of the free flagellin. The immunization of mice with the recombinant lactobacilli did not result in antigen-specific antibody responses in either feces or sera but did induce the release of interferon (IFN)-γ on restimulation of primed lymphocytes ex vivo. These results suggested that the protective efficacy provided by flagellin expressing L. caseiwas mainly attributable to cell mediated immune responses. When the levels of IFN-γ produced by primed and flagellin restimulated lymphocytes were compared between the recombinant L. caseicells expressing flagellin on their cell surface, and a mixture of the purified flagellin and normal L. casei, the results indicated that the Lactobacillusstrain showed adjuvanticity only when the flagellin was expressed on the cell surface (Kajikawa et al., 2007).

Two recombinant L. acidophilusstrains displaying flagellin of Salmonella typhimuriumon the cell surface were constructed using different anchor motifs. In one construct, the flagellin gene was fused at its carboxy end to the C-terminal region of PrtP of L. acidophilus. In other construct, the flagellin gene was fused in the same way to the anchor region of mucus binding protein (Mub) of L. acidophiluscontaining an LPXTG motif. The density of the flagellin fused protein at the cell surface of L. acidophilusdisplaying the flagellin by the PrtP protein (FliC-PrtP) was higher than that of L. acidophilusdisplaying the antigen by the Mub anchor (FliC-Mub). Both of the recombinant lactobacilli showed TLR5 stimulating activity, which indicated that the surface associated flagellin was recognized by TLR5. The magnitude of the TLR5 stimulating activity of L. acidophiluscells expressing FliC-PrtP was higher than that of L. acidophiluscells expressing FliC-Mub and this result showed that the magnitude of the TLR5 stimulating activity was dependent on the quantity of surface located flagellin. Moreover, the two recombinant lactobacilli exhibited dissimilar maturation and cytokine production by human myeloid dendritic cells (Kajikawa et al., 2011).

Human papillomavirus type 16 (HPV-16) has been associated with more than 50% of HPV related cervical cancer (CxCa) (Krinbauer et al., 1992). HPV-16 E7 oncoprotein is constitutively expressed in CxCa cells during malignant progression of HPV-16 induced cervical lesions and is therefore considered as an effective target for the cancer immunotherapy. L. lactiswas engineered to express HPV-16 E7 on the cell surface (LL-E7) using the M6 anchor and its coadministration with another lactococci secreting IL-12 (LL-IL-12) was investigated for the immunization and immunotherapy of HPV-related CxCa. IL-12 is a heterodimeric cytokine that induces Th1 responses, enhances cytotoxic T-lymphocyte (CTL) maturation, promotes natural killer (NK) cell activity and induces IFN-γ production. Mice were vaccinated intranasally with LL-E7 and were then challenged by injection of tissue culture number 1 (TC-1) tumor cells. Thirty five percent of the vaccinated mice remained tumor free. Coadministration of LL-IL-12 with LL-E7 resulted in higher antitumor activities as half of the inoculated mice remained tumor free and the tumor median size in the remaining tumor bearing animals was less than that in LL-E7 immunized mice. Antitumoral activity elicited by covaccination with LL-E7 and LL-IL-12 appeared to be long lasting as when the tumor free animals were rechallenged 3 months later with TC-1 cells, they remained tumor free for up to 6 months. To investigate the therapeutic effects of the coadministration of LL-E7 and LL-IL-12, mice were challenged with the TC-1 tumor cell line prior to the initiation of immunotherapy. Once 100% of the mice had palpable tumor, the immunotherapy was started. Only LL-E7/LL-IL-12 treatment resulted in total tumor regression in 35% of the immunized animals. Moreover, the tumor median size in the remaining tumor bearing mice was lower than that measured in mice treated with LL-E7. In contrast, no tumor regression was observed in mice treated with LL-E7 alone. Mice immunized with LL-E7/LL-IL-12 also exhibited both systemic and mucosal humoral responses, which were induced at higher levels than those in mice vaccinated with LL-E7 (Bermudez-Humaran et al., 2005).

Boiling of L. lactiscells in TCA followed by washing and neutralization resulted in nonviable spherical peptidoglycan microparticles, which are deprived of surface proteins and their intracellular content is largely degraded. The proteins IgA1 protease (IgA1p), putative proteinase maturation protein A (PpmA) and streptococcal lipoprotein A (SlrA) were bound to the surface of the lactococcal particles after recombinant production of the antigens as hybrids with the CpH domain. TCA removes (lipo) teichoic acids from the lactococcal cell wall that results in enhancement of the binding capacity for CpH fusions. Mice immunized intranasally with the monovalent lactococcal particle based vaccines were not protected against an intranasal pnemococcal challenge. However, intranasal immunization with a trivalent vaccine containing PpmA, SlrA and IgA1p bound to the lactococcal particles by the CpH domain showed protection against fatal pneumococcal pneumonia in mice (Audouy et al., 2007).

3.2. Development of whole cell biocatalysts

Cellulosome is a multi enzyme complex in which various cellulytic enzymes assemble into a macromolecular structure by their attachment to a nonenzymatic central scaffold protein for the efficient degradation of cellulose (Bayer et al., 2004; Demain et al., 2005). Cellulosome of the gram positive thermophile Clostridium thermocellumis anchored to the surface of cells, resulting in one of the most efficient bacterial systems for the cellulose hydrolysis. All of the cellulosomal enzymes of C. thermocellumcontain a twice repeated sequence, usually at their C-termini, called type I dockerin domain. These dockerin domains are considered to bind to the hydrophobic domains termed cohesins, which are repeated nine times in the central scaffold protein (CipA) of the bacterium. CipA also contains a cellulose binding module (CBM3a), allowing the different cellulases to act in synergy on the crystalline substrate, as well as a type 2 dockern domain, which binds the cell surface anchor proteins, ensuring the cellulosome’s attachment to the cell surface. Association of the cellulosome with the cell surface yields formation of cellulose-enzyme-microbe ternary complexes and results in enhanced activity and synergy (Begum et al., 1996). The assembly of recombinant cellulosome inspired complexes on the cell surface of surrogate hosts such as LAB is highly desirable. LAB can produce commodity chemicals such as lactic acid and bioactive compounds (De Vuyst & Leory, 2007; Hofvendahl & Han-Hagerald, 2007; Siragusa et al., 2007). The economics of these processes would be greatly improved if LAB could utilize cellulosic substrates, which are cheap and abundant. While most of LAB can not assimilate cellulose, by the display of cellulosome on the surface of these bacteria, the hydrolysis of cellulosic substrates and the fermentation of hydrolysis products to desirable compounds can be carried out in a single step process, which has economical advantages. As a key step in the development of these recombinant LAB, fragments of CipA were functionally expressed on the cell surface of L. lactis. The fragments engineered to contain a single cohesin module, two cohesin modules, one cohesin and CBM3a, or only CBM3a. Cell toxicity from over expression of the proteins was circumvented by use of the nisin A (nisA) inducible promoter. Incorporation of the C-terminal anchor motif of the streptococcal M6 protein in the expression cassette resulted in the successful surface display of the fragments. All of the constructs containing cohesin modules were able to bind to an engineered hybrid reporter enzyme, E. coliß-glucuronidase fused to the type I dockerin domain of a cellusomal enzyme. These results demonstrated that the cohesins were displayed on the cell surface of L. lactiscells in the functional form. In addition, the cell surface complex formation was dependent on the presence of both cohesin and dockerin modules (Wieczorek & Martin, 2010).

The process for the conversion of starch to lactic acid by LAB includes the enzymatic hydrolysis of starch followed by the fermentation of resultant oligosaccharides to lactic acid by LAB. These steps can be carried out simultaneously by α-amylase displaying LAB. Therefore, using these whole cell biocatalysts can result in economical benefits for the conversion of starch to lactic acid. The PgsA anchor protein was fused to the N-terminus of α-amylase of Streptococcus bovis148 (AmY). The resulting fusion protein expressed in L. caseiand it was associated with the membrane and cell wall fractions. However, the status of exposure of AmY outside of the cell wall was not clarified. The constructed whole cell biocatalyst was able to convert starch to lactic acid. Because the lactic acid concentration increased as the total sugar concentration decreased, it was concluded that the lactic acid was produced by simultaneous saccharification and fermentation of starch. The yield of lactic acid was improved by repeated utilizations of the recombinant L. caseicells (Narita et al., 2006).

The C-terminal region of peptidoglycan hydrolase (AcmA) of L. lactisIL 1403 (CphI) is a homolog of CpH of L. lactisMG 1363 and it contains three LysMs. CphI can bind to the surface of various LAB (Tarahomjoo et al., 2008a). We studied the capability of CphI for the development of α-amylase displaying LAB using the external mode of protein display. These whole cell biocatalysts are expected to be effective for the direct fermentation of starch to lactic acid. Starch is a large substrate that is not capable of penetrating the cell wall. For this reason, in order to achieve its efficient hydrolysis, the enzyme must be exposed on the outside of the cell wall such that it is accessible to starch. The display systems based on the internal mode of protein anchoring often have limited ability for the translocation of target proteins to the cell surface. In contrast, the display systems based on the external mode of protein anchoring can display the enzyme completely outside of the cell wall. Therefore, a whole cell biocatalyst constructed using the externally added cell surface adhesive α-amylase is considered as a suitable selection for our purpose. Moreover, the cell surface adhesive α-amylase can readily be recovered together with LAB cells at the end of starch conversion process for reuse. CphI fused to AmY either at its C-terminus (CphI-AmY) or at its N-terminus (AmY-CphI) was expressed in E. coli. Both of the fusion proteins were able to bind to the cell surface of L. lactisATCC 19435. Therefore, CphI is considered as a bidirectional anchor protein. However, the number of bound molecules per cell in the case of CphI-AmY was 3 times greater than that in the case of AmY-CphI. The change in the fusion direction may cause conformational alterations in the fusion protein leading to a better accessibility of CphI for the cell surface binding and an increase in the number of bound molecules. Moreover, the specific activity for starch digestion of CphI-AmY was 11 fold higher than that of AmY-CphI. The starch binding domain of AmY is located at its C-terminus. As a result, the fusion of CphI to the N-terminus of AmY may help improve the adsorption of starch onto the enzyme and enhance starch degradation, resulting in a higher specific activity for starch digestion. In addition to L. lactisATCC 19435, L. plantarumNRRL B531, L. lactisIL1403, L. caseiNRRL B441, L. delbrueckiiATCC 9649 and L. caseiNRRL B445 were examined in terms of the binding of CphI-AmY. Of the LAB tested, L. lactisATCC 19435 showed the highest binding capability for CphI-AmY, up to 6×104 molecules per cell. The binding of CphI-AmY to L. delbrueckiiATCC 9649 cells was very stable and its dissociation rate constant at 37°C was 7×10­6 s-1 (the half life of binding (t1/2) was 28 h). The binding of this protein to cells of L. lactisATCC 19435 was also stable, with a dissociation rate constant of 5×10­5 s-1 at 30°C (t1/2=4 h). Lactate production by lactic acid bacteria is maximal during the exponential growth phase. Therefore, for a successful application of the constructed whole cell biocatalysts in lactate production, suitable fermentation conditions should be specified to adjust the duration of the exponential growth phase with respect to the dissociation rate of the protein. These half lives are long enough for lactic acid fermentation when the inoculm size is adequet and/or suitable growth conditions with high specific growth rates are used (Tarahomjoo et al., 2008a). A CphI mutant devoid of its N-glycosylation sites was expressed extracellularly in Pichia pastoris. This domain was able to bind to the cell surface of L. casei. However, its dissociation rate constant from the cell surface was 3.5 fold lower than that of CphI. These results indicated that the protein engineering approaches can be useful for increasing the binding stability of noncovalent anchors (Tarahomjoo et al. 2008b).

3.3. Attachment of bacteria to host tissues

Display of adhesins capable of binding to a host tissue on the surface of LAB can provide them with a specific adhesion capability, which can be beneficial when LAB are used as mucosal delivery vehicles of bioactive compounds. Because the displayed adhesins can increase the persistence of bacteria in the host tissue and as a result, the desired effects of the delivered bioactive compounds can be enhanced. The N-terminal region of SlpA was recently shown to mediate adhesion to human intestinal cell lines in vitro. The SlpA adhesion mediating domain fused to the N-terminus of lactococcal CpH protein was expressed in L. lactis. To increase the surface accessibility of the hybrid protein, a part of PrtP of L. lactissubsp. cremorisWg2 was used as a spacer protein, which could extend the SlpA receptor binding region out of the cell surface. The spacer was inserted between the receptor binding domain and the anchor protein. In vitroadhesion assay with the human intestinal epithelial cell line Intestine 407 indicated that the recombinant lactococcal cells had gained an ability to adhere to Intestine 407 cells significantly greater than that of parental nonrecombinant L. lactiscells (Avall-Jaaskelainen et al., 2003).

It has been reported that Mycobacterium bovisbacillus Calmette-Guerin (BCG) exerts antitumor effects against superficial bladder cancer. These antitumor effects are due to the activation of immune responses, which are mediated by the attachment of BCG to the bladder wall through fibronectin. In addition, L. caseistrain Shirota showed an antitumor activity when it was administered to the mouse model of superficial bladder cancer. However, the L. caseicells exhibits no significant binding to fibronectin. Therefore, higher antitumor activity could be expected for the L. caseicells genetically engineered to acquire binding capacity to fibronectin. For this purpose, fibronectin binding domain (FbD) of S. pyogenesATCC 21059 fused to the C-terminal region of PrtP 763 of L. lactisNCDO 763 was expressed in L. caseistrain Shirota. The recombinant L. caseicells were able to bind to fibronectin. Furthurmore, FbD expressed on the L. caseicell surface promoted the adherence to murine fibroblast STO cells, which secret fibronectin in large amounts (Kushiro et al., 2001).

3.4. Enhancement of delivering viable bacteria to gastrointestinal tract

Probiotics are live microbial food supplements, which benefit the health of consumers by improving their intestinal microbial balance (Fuller, 1989). Since the viability and activity of a probiotic is essential at the site of action, it must survive the harsh environment of the upper GIT, and it must be able to function in the gut environment (Collins et al., 1998). Most commonly used probiotics are lactobacilli and bifidobacteria (Daly & Davis, 1998). However, several studies indicate that most of these bacteria may not be able to withstand the harsh acidity of the upper GIT (Conway et al., 1987; Lankaputhra & Shah, 1995). In a study by Wang (1999), the enhancement of survival of bifidobacteria grown in the presence of starch granules and mixed with them was reported. However, the exact mechanism underlying the protective effect of starch was not clarified. The adhesion of bacteria to starch was considered as a possible explanation for these observations. The results of their study suggested that starch granules can be used to protect living microbes from environmental stress factors.

Microencapsulation is an approach that has been proposed to protect probiotics from environmental stresses. It segregates cells from adverse environments; thus, it minimizes cell injury (Anal & Singh, 2007). Myllaerinen (1999) has recently developed a microencapsulation technology that involves entrapping bacteria in the hollow cores of partially hydrolyzed starch granules, which are then encapsulated in an outer coating of amylose. The aim of this technology is to protect the probiotic bacteria from adverse environmental conditions during processing, in products during storage, and during passage through the GIT, and it is based on the finding that starch granules can be used to protect living microbes from adverse environments.

We therefore aimed to investigate whether the conferment of starch adhesion ability to cells and using this characteristic to encapsulate the cells between starch granules can enhance their viability in simulated gastric conditions. However, using genetic engineering techniques to confer starch binding ability to probiotics is not favorable because of consumers’ concerns about genetically modified food ingredients. CphI of Lactococcus lactisIL1403 is an efficient anchoring domain for the display of heterologous proteins on LAB cells, which can bind to the cell surface when added from the outside (Tarahomjoo et al., 2008a). This domain can be used to confer starch binding ability to LAB without making any genetic modifications in them. We therefore studied the capability of the CphI anchor to direct the display of a starch binding domain (SbD) on the surface of L. caseicells and the aggregation of cells with starch was examined as an alternative technique of microencapsulation. This is the only available report demonstrating the potential applicability of the cell surface display technology for increasing the delivery of viable microorganisms to the GIT.

3.4.1. Materials and methods Bacterial strains and growth conditions

E. coliXL1-Blue was used for the construction of vectors and the expression of heterologous proteins. It was grown in Luria-Bertani (LB) liquid medium or on LB agar plates at 37ºC. L. caseisubsp. caseiNRRL B-441 (Agriculture Research Service Culture Collection, Peoria, IL, USA) was used for the binding assay, and it was grown at 37°C in MRS broth (Difco Laboratories, Detroit, MI, USA). DNA manipulation

The gene encoding the linker region and the first nine amino acid residues of SbD of the AmY was prepared by PCR from pQE31amyA (Shigechi et al., 2004) with 5′-aaggatccgggccaagctagccaagcagctc-3′ and 5′-gcgccaattatctgggttttgg-3′ as forward and reverse primers, respectively. The amplified fragment was digested with BamHI and BstXI and inserted at the same restriction sites into pQCA (Tarahomjoo et al., 2008a). The obtained plasmid was designated as pQCLS, in which the gene encoding CphI was fused at its C-terminus to the gene encoding the linker region and SbD of AmY. The correctness of the construct was confirmed by restriction digestion and sequencing. Expression studies

E. colicells harboring the desired plasmids were grown overnight at 37ºC in LB broth supplemented with 100 µg/ml ampicillin and 15 µg/ml tetracycline. The cells were then harvested by centrifugation and transferred to fresh LB broth containing the antibiotics mentioned above, and incubated at 37ºC until the OD600 reached 0.5. Isopropyl β-d-thiogalactoside (IPTG) was added to a final concentration of 1 mM to induce the expression of the target protein. At the same time, ampicillin was added to a final concentration of 400 µg/ml for plasmid maintenance. After further incubation for 4 h, the cells were collected and the expression was studied by resolving the whole-cell extracts by 12.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and staining the gel using Coomasie Brilliant Blue R250 (CBB). Purification of fusion protein

Proteins were purified under native conditions by metal affinity chromatography, utilizing the interaction between the histidine tag and a nickel chelate column (Ni-NTA superflow column [1.5 ml]; Qiagen GmbH, Hilden, Germany). The induced cells from a 100-ml culture were harvested by centrifugation and were resuspended in binding buffer (50 mM NaH2PO4 (pH 8), 300 mM NaCl, 10 mM imidazole). Lysozyme was added to a final concentration of 1 mg/ml and the cell suspension was incubated for 1 h on ice. The cells were disrupted by sonication and the clear supernatant obtained by centrifugation was applied to the Ni-NTA column equilibrated with the binding buffer. The column was washed three times with the same buffer containing 20 mM imidazole and the bound proteins were eluted with the elution buffer, which was the same as the binding buffer except that it contained 250 mM imidazole. The buffer of the eluent was then exchanged to 20 mM Tris-Cl buffer (pH 8.0) by ultrafiltration. The protein preparation was applied to an anion exchange column (SuperQ-5PW,, Tosoh, Tokyo, Japan) equilibrated with 20 mM Tris-Cl buffer (pH 8.0). The absorbed proteins were eluted by a linear NaCl gradient (0−1M). Protein elution was monitored using a UV detector, and the desired fraction was collected and desalted by ultrafiltration. Purified proteins were subjected to 12.5% SDS-PAGE and the bands were visualized by CBB staining. Gels were scanned using a GT-F600 scanner (Epson, Suwa, Japan) and densitometrical analysis was performed with Scion image software (Scion, MD, USA) to quantify the proteins. Cell surface binding assay

L. caseicells were grown as mentioned above until an OD660 of 1 was achieved. The cells from a 1.5 ml culture were dispersed in 0.15 ml of de-Man Rogosa Sharp (MRS) medium containing the purified fusion protein at 0.12 mg/ml and incubated at 30ºC for 2 h with gentle shaking. After washing the cells twice with 0.1 M phosphate buffer (PB) (pH 7.0), the cell pellets were resuspended in 2×SDS-PAGE loading buffer containing 20% (w/v) glycerol, 125 mM Tris-HCl (pH 6.8), 4% SDS, 5% (v/v) β-mercaptoethanol, and 0.01% bromophenol blue, and boiled for 5 min. Binding of the protein to the cells was studied by 12.5% SDS-PAGE followed by CBB staining and the amount of the fusion protein bound to the cells was determined by densitometrical analysis of CBB stained gels as mentioned above. Starch binding assay

The fusion protein (0.06 mg/ml in PB) was mixed with an equal volume of a suspension of starch granules (Corn starch, Sigma-Aldrich Tokyo, Japan) (10 mg/ml) in the same buffer and incubated at 37°C for 2 h with gentle shaking. After centrifugation, the supernatant was examined for the presence of unbound proteins by 12.5% SDS-PAGE and CBB staining. Aggregation of bacteria with starch and microencapsulation

After performing the cell surface binding assay as described above, the cells were washed and resuspended in PB to a final density of 109 cells/ml. The suspension of the starch granules in PB was mixed with an equal volume of the cell suspension for 30 min. The mixture was then allowed to stand at room temperature for 1 h. The formation of aggregates was studied both visually and with phase contrast microscopy. To determine the percentage of cells adhering to starch, a 0.5 ml sample was taken from below the liquid surface after the sedimentation. Optical density at 540 nm was measured and compared with those of controls including bacteria without starch and starch without bacteria to calculate the starch adhesion percentage as described by Crittenden (2001). For coating of the aggregates with amylose, a 1% solution of amylose in water (amylose from potato, Sigma –Aldrich, Tokyo, Japan) was prepared by heating it to a temperature of 170°C in a pressure heater (Taiatsu Techno, Tokyo, Japan), which was then cooled down to about 37°C. The aggregates were mixed gently with 0.5 ml of the amylose solution and the coating was allowed to form overnight at 4°C. Survival of cells in simulated gastric juice

Simulated gastric juice (SGJ) was prepared as described by Lian (2003), which was a pepsin solution (3 g/l) in saline (0.5% NaCl). The SGJ was prepared freshly and its pH was adjusted to 2.0 or 3.0 with 5 M HCl. The cells (5×107 cfu) were mixed with 1 ml of the filter sterilized SGJ and incubated at 37°C. At specified time intervals, the gastric juice was removed following centrifugation and the cells were washed once with PB following with two washes with saline. Amylose coated cells were then resuspended in PB containing 30 U/ml α-amylase (Megazyme, Bray, Ireland) and incubated at 40°C for 20 min to aid the release of cells from the encapsulating materials. Viable bacteria were enumerated on MRS-agar after incubation for 24 h at 37°C and survival percentage was determined by dividing the final viable population (cfu/ml) with the initial viable population (cfu/ml) of L. caseicells exposed to the SGJ.

3.4.2. Results Expression and purification of fusion protein

To investigate the capability of CphI for the construction of a cell surface adhesive SbD, this domain was fused at its C-terminus to the linker region and SbD of AmY (Fig. 2). The fusion protein (CphI-SbD) was expressed intracellularly in E. coliusing the T5 promoter at 0.35 g/l. The molecular size was 56 kDa as expected and 75% of the protein was present in the soluble form. When the protein was purified under native conditions by the histidine tag affinity chromatography, two additional protein bands corresponding to 73 and 71 kDa were present in the protein preparation (Fig. 3, lane 1). After incubation of the protein preparation with corn starch, no band for CphI-SbD was detected in the supernatant indicating its adsorption to the starch granules (Fig. 3, lane 2). CphI-SbD was further purified using an anion exchange chromatography (Fig. 3, lane 4). The result of starch binding assay showed that the purified fusion protein was in the active form and it was able to adhere to the starch granules (data not shown).

Figure 2.

Structure of expression cassette

Figure 3.

Purification of CphI- SbD and its binding to corn starch andL. caseicells. Lane 1, nickle chelate column purified protein preparation; lane 2, supernatant after starch binding assay; lane 3, control without starch; lane 4, ion exchange chromatography purified CphI-SbD; lane 5, cells bound to CphI-SbD; lane 6, cells only. Binding of CphI-SbD to L. casei cells

L. caseicells were incubated with the purified fusion protein and studied in terms of the binding of the fusion protein by SDS-PAGE. As shown in Fig. 3 (lane 5), the fusion protein was associated with the cells. The result of the densitometrical analysis showed that 6×104 molecules of CphI-SbD were bound to each cell of L. casei. Aggregation of bacteria with starch

For aggregation of bacteria with starch, an optimal ratio between bacteria and starch must be determined. Therefore, we examined the dependence of aggregate formation on the final starch concentration in the mixture at a constant cellular density. Free cells mixed with starch, and starch without cells were used as controls. For each concentration of starch, we compared the volume of sediment formed in the sample containing the mixture of bacteria bound to CphI-SbD and starch with those of the controls visually. The result is shown in Table 1. The volumes of the sediments formed in the controls after 1 h standing at room temperature, were almost the same at all the starch concentrations tested. When the starch concentration was 5 mg/ml, the volume of formed sediment in the sample containing the mixture of bacteria bound to CphI-SbD and starch was markedly larger than those of the controls. The adhesion percentage of L. caseicells to the starch granules under these conditions was determined by cosedimentation assay, which measures the reduction in optical density in bacterial suspensions after the addition of starch (Crittenden et al., 2001), and it was 32% for the bacteria bound to CphI-SbD and 4% for the free cells.

Starch concentration (mg/ml)BPS1BS2S3

Table 1.

Comparison of sediment formation at different starch concentrations.

Mixing of the bacteria bound to CphI-SbD with starch at a final concentration of 5 mg/ml resulted in the crosslinking of starch granules and the formed aggregates were observed by phase contrast microscopy (Fig. 4). In contrast, when starch was mixed with free cells or when no bacteria were present in the mixture, the starch granules were found to be separated from each other and no aggregates were observed by phase contrast microscopy (data not shown).

Figure 4.

Aggregation ofL. caseicells displaying CphI-SbD with starch granules (scale bar=5 μm) Survival of encapsulated cells under simulated gastric conditions

When L. caseifree cells were exposed to the SGJ at pH 3.0 and 2.0 for 1 h, the survival percentages of the cells were 0.074% and 0.002%, respectively. However, the survival percentages of amylose coated bacterial aggregates after 1 h incubation in the SGJ were 63.9% and 6.03% at pH 3.0 and 2.0, respectively (Fig. 5).

We studied the effects of starch, amylose coating and CphI-SbD on cell survival in the SGJ (pH 3.0, 1 h) (Table 2). It was observed that when free cells were mixed with the starch granules, the survival percentage was 3.1%, and the survival percentage of amylose coated free cells in the SGJ was 7.2%. The survival of the CphI-SbD displaying bacteria (0.093%) was not significantly different from that of free cells (0.074%) and the survival of amylose coated fusion protein displaying bacteria was comparable to that of amylose coated free cells. However, when fusion protein displaying bacteria were aggregated with the starch granules, the survival percentage was 7.7% higher than that of free cells mixed with the starch granules, and when the aggregates were coated with amylose, the survival percentage was 27.6% higher than that of the amylose coated mixture of the starch granules and free cells.

Figure 5.

Time course of survival ofL. caseicells under simulated gastric conditions. Open and filled triangles are free cells and amylose coated bacterial aggregates, respectively at pH 3.0; Open and filled rectangles, those at pH 2.0. The Data represent the means of two independent experiments.

BacteriaCphI-SbDStarchAmyloseSurvival (%)
+0.074 ± 0.012
++0.093 ± 0.018
++3.1 ± 0.4
+++10.8 ± 2.0
++7.2 ± 1.7
+++6.6 ± 2.5
+++36.3 ± 5.4
++++63.9 ± 2.7

Table 2.

Effects of protective systems components on cell survival. Data represent means± standard deviations of three independent experiments.

3.4.3. Discussion

The objective of this study was to evaluate the possibility for enhancement of the delivery of viable microorganisms to the GIT through the conferment of starch binding ability to them. In this way, the bacteria are entrapped between starch granules to use the protective effect of starch for maintaining the cell viability under adverse conditions. The surface display technology based on the external mode was used to provide starch adhesion ability for the cells while retaining their nongenetically modified status because consumption of genetically modified microorganisms is not favorable for consumers. It was observed that CphI-SbD was able to bind both to the cell surface of L. caseiand to the starch granules. Therefore, the fusion protein was able to mediate the adhesion of cells to the starch granules. We examined the aggregation of cells with starch as an alternative protective strategy, which entraps bacteria between starch granules. Compared with the previous method of entrapping bacteria within the porous starch granules prepared by an enzymatic digestion (Myllaerinen et al., 2001), our technique, is much simpler and faster. Moreover, starch granules can be used in their intact forms without any modifications.

When the aggregates of CphI-SbD displaying bacteria with starch were coated with amylose and exposed to the SGJ, there were significant increases in the survival percentage (63.9% at pH 3.0, and 6.03% at pH 2.0) with respect to those of free cells (0.074% at pH 3.0, and 0.002% at pH 2.0). The pHs of the SGJ measured for all the combinations of bacteria, fusion protein, starch and amylose coating (Table 2), in addition to that of the SGJ without any of these components both before and after the incubation at 37°C, were in the range of 3.00- 3.04. Therefore, the observed increases in the survival were not due to the modifications of the pH of SGJ.

Analysis of the effects of fusion protein, starch and amylose coating on the cell survival showed that the binding of fusion protein to L. caseicells did not have a significant effect on the cell survival (Table 2). When free cells were mixed with the starch granules, their survival percentage was 3.03% higher than that of free cells, which indicated the protective effect of starch on the cell survival. It was observed that, the entrapment of bacteria between the starch granules with the aid of CphI-SbD (the aggregation of bacteria with the starch granules) enhanced the protective effect of starch, and the survival percentage was increased to 10.8%. The effect of the amylose coating on the survival of CphI-SbD displaying bacteria was comparable to that of the free cells (6.6 and 7.2% respectively), and the observed difference was not statistically significant. Incorporation of the fusion protein in the protective system composed of the starch and amylose resulted in a 27.6% increase in the cell survival percentage, which showed that the simultaneous application of two protective strategies (the aggregation of bacteria with starch and the amylose coating) resulted in the highest cell survival percentage (63.9%). In conclusion, in this study we showed the potential usefulness of the cell surface display technology for protection of cells under adverse gastric conditions.


4. Conclusion

Surface display is an attractive technology that can be used to confer new functions to LAB. The effectiveness of these systems depends on the appropriate selection of several factors including the anchoring domains, secretion signals, and host strains. Moreover, a proper strategy for the fusion of anchoring domains to target proteins should be determined to protect the functionality of target proteins. So far, a limited number of surface display systems have been developed. The characterization of anchoring, secretion, and regulatory signals from genome sequences can expand the surface display systems. The low transformation efficiency of LAB is a major obstacle for the construction of surface display systems and the establishment of efficient transformation protocols is therefore necessary.


  1. 1. AnalA. KandSinghH2007Recent advances in microencapsulation of probiotics for industrial applications and targetd delivery.Trends Food Sci Technol18, 240-251 (2007).
  2. 2. AntikainenJAntonLSillanpääJKorhonenT. K2002Domains in the S-layer protein CbsA ofLactobacillus crispatusinvolved in adherence to collagens, laminin and lipoteichoic acids and in self-assembly. Mol Microbiol46381394
  3. 3. AudouyS. A. LVan SlemSVan RoosmalenM. LPostEKanningaRNeefJEstevaoSNieuwenhuisE. SAdrianP. VLeenhoutsKAnd Hermans, P. W. M. (2007Development of lactococcal GEM based pneumococcal vaccines.Vaccine2524972506
  4. 4. Avall-jääskeläinenSKyla-nikkilaKKahalaMMiikkulainenTandPalavA2002Surface display of foreign epitopes on theLactobacillus brevisS-layer. Appl Environ Microbiol6859435951
  5. 5. Avall-jääskeläinenSLindholmAAnd Palva, A. (2003Surface display of the receptor binding region of the Lactobacillus brevis S-layer protein inLactococcus lactisprovides nonadhesive lactococci with the ability to adhere to intestinal epithelial cells. Appl Environ Microbiol6922302236
  6. 6. Avall-jääskeläinenSHynönenUIlkNPumDSleytrU. BandPalvaA2008Identification and characterization of domains responsible for self-assembly and cell wall binding of the surface layer protein ofLactobacillus brevisATCC 8287. BMC Microbiol8165181
  7. 7. AxelssonL1998Lactic acid bacteria: classification and physiology. In Lactic acid bacteria: Microbiology and functional aspects, Salminen S. and Wright A. W. Marcel Dekker Inc., New York.
  8. 8. BayerE. ABelaichJ. PShohamYandLamedR2004The cellulosomes: multienzyme machines for degradation of plant cell wall polysaccharides.Ann Rev Microbiol58521554
  9. 9. BegumePandLemaireM1996The cellulosome: an extracellular multiprotein complex specialized in cellulose degradation.Critic Rev Biochem Mol Bio31201236
  10. 10. BerlecAZadravecPJevnikarZandStrukeljB2011Identification of candidate carrier proteins for surface display onLactococcus lactisby theoretical and experimental analysis of the surface proteom. Appl Environ Microbiol7712921300
  11. 11. Bermudez-humaranL. GCortes-perezN. GLefeverFGuimaraesVRabotSAlcocer-gonnzalezJ. MGratadouxJ-JRodriguez-padillaCTamez-guerraR. SCorthierGGrussAandLangellaP2005A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors.J Immunol17572977302
  12. 12. BrinsterSFurlanSSerrorP2007C-terminal WXL domain mediates cell wall binding inEnterococcus faecalisand other gram positive bacteria. J Bacterio18912441253
  13. 13. BuistGKokJLeenhoutsK. JBabrowskaMVenemaGandHaandrikmanA. J1995Molecular cloning and nucleotide sequence of the gene encoding the major peptidoglycan hydrolase ofLactococcus lactis, a muramidase needed for cell separation. J Bacteriol17715541563
  14. 14. Buist,G.,Steen,A.,Kok,J. andKuipers,O. P. (2008).LysM, a widely distributed protein motif for binding to (peptide)glycans. Mol Microbiol 68, 838-847.
  15. 15. CollinsJ. KThorntonandGSullivanG. O1998Selection of probiotic strains for human applications.Int Dairy J8487490
  16. 16. ConwayP. LGorbaschS. LandGoldinB. R1987Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells.J dairy Sci70112
  17. 17. CrittendenRLaitilaAForssellPMattoJSaarelaMMattilla-sandholmTandMyllarinenP2001Adhesion of bifidobacteria to granular starch and its implications in probiotic technologies. Appl Environ Microbiol6734693475
  18. 18. CurtissR2002Bacterial infectious disease control by vaccine development.J Clin Invest11010611066
  19. 19. DalyCandDavisR1998The biotechnology of lactic acid bacteria with emphasis on applications in food safety and human health.Agric Food Sci7, 219-250 (1998).
  20. 20. DemainA. LNewcombMandWuJ. H. D2005Cellulase, clostridia and ethanol.Microbiol Mol Biol Rev69124154
  21. 21. De VuystLandLeoryF2007Bacteriocins from lactic acid bacteria: production, purification, and food applications.J Mol Microbiol Biotechnol13194199
  22. 22. DieyeYHoekmanA. J. WClierFJuillardVBootH. JandPiardJ-C2003Ability ofLactococcus lactisto export viral capsid antiges: a crucial step for development of live vaccines. Appl Environ Microbiol6972817288
  23. 23. FischettiV. APancholiVandSchneewindO1990Conservation of a hexapeptide sequence in the anchr region of surface proteins from gram positive cocci.Mol Microbiol416031605
  24. 24. FrankeC. MLeenhoutsK. JHaandrikmanA. JKokJVenemaGandVenemaK1996Topology of LcnD, a protein implicated in the transport of bacteriocins fromLactococcus lactis. J Bacteriol17817661769
  25. 25. FullerR1989Probiotics in man and animals.J Appl Bacteriol66365378
  26. 26. GermondJ-EDelleyMGilbertCandAtlanD2003Determination of the domain of theLactobacillus delbrueckiisubsp. bulgaricus cell surface proteinase PrtB involved in attachment to the cell wall after heterologous expression of the prtB gene in Lactococcus lactis. Appl Environ Microbiol6933773384
  27. 27. GiudiceE. LandCampbellJ. D2006Needle free vaccine delivery.Adv Drug Deliv Rev586889
  28. 28. HanssonMSamuelsonPGunneriussonEandStahlS2001Surface display on gram positive bacteria. Comb.Chem High throuput Screen4171184
  29. 29. HofvendahlKandHan-hagerdalB2000Factors affecting the fermentative lactic acid production from renewable resources.Enz Microbial Technol2687107
  30. 30. HouX-LYuL-YLiuJandWangG-H2007Surface-displayed porcine epidemic diarrhea viral (PEDV) antigens on lactic acid bacteria.Vaccine262431
  31. 31. HuSKongJKongWGuoTandJiM2010Characterization of a novel LysM domain fromLactobacillus fermentumbacteriophage endolysin and its use as an anchor to display heterologous proteins on the surfaces of Lactic acid bacteria. Appl Environ Microbiol7624102418
  32. 32. HuSKongJSunZHanLKongWandYangP2011Heterologous protein display on the cell surface of lactic acid bacteria is mediated by the s-layer protein.Microbial Cell Factories10, 86.
  33. 33. KajikawaASatohELeerR. JYamamotoSandIgimiS2007Intragastic immunization with recombinantLactobacillus caseiexpressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis. Vaccine2535993605
  34. 34. KajikawaANordoneS. KZhangLStoekerL. LLaVoy, A. S., Klaenhammer, T. R. and Dean, G. A. (2011Dissimilar properties of two recombinantLactobacillus acidophilusstrains displaying Salmonella FliC with different anchoring motifs. Appl Environ Microbiol7765876596
  35. 35. KleerebezemMBoekhorestJVan KranenburgRMolenaarDKuipersO. PLeerRTarchiniRPetersS. ASandbrinkH. MFiersM. WStiekemaWLankhorstR. MBronP. AHofferS. MGrootM. NKerkhovenRDe VriesMUrsingBDe VosW. MandSiezenR. J2003Complete genome sequence ofLactobacillus plantarumWCFS1. Proc Natl Acad Sci USA10019901995
  36. 36. KleerebezemMHolsPBernardERolainTZhouMSiezenR. JandBronA2010The extracellular biology of the lactobacilli. FEMS Microbiol Rev34199230
  37. 37. KondoAandUedaM2004Yeast cell-surface display- applications of molecular display.Appl Microbiol Biotechnol642840
  38. 38. KrinbauerRBooyFChengNLowyD. RandSchillerJ. T1992PapillomavirusLmajor capsid protein self assembles into virus-like particles that are highly immunogenic.Proc Natl Acad Sci USA891218012184
  39. 39. KushiroATakahashiTAsaharaTTsujiHNomotoKandMorotomiM2001Lactobacillus caseiacquires the binding activity to fibronectin by the expression of the fibronectin binding domain of Streptococcus pyogenes on the cell surface. J Mol Microbiol Biotechnol3563571
  40. 40. LankaputhraW. E. VandShahN. P1995Survival ofLactobacillus acidophilusand Bifidobacterium spp. in the presence of acid and bile salts. Cultured Dairy Products J3027
  41. 41. LeeJ-SPooHHanD. PHongS-PKimKChoM. WKimESungM-HandKimC-J2006Mucosal immunization with surface displayed severe acute respiratory syndrome coronovirus spike protein onLactobacillus caseiinduces neutralization antibodies in mice. J Virol8040794087
  42. 42. LeePandFaubertG. M2006Expression of theGiardia lambliacyst wall protein 2 in Lactococcus lactis. Microbiol15219811990
  43. 43. LeeS. YChoiJ. HandXuZ2003Microbial cell-surface display.Trends Biotechnol214552
  44. 44. LiY-JMaG-PLiG-WQiaoX-YGeJ-WTangL-JLiuMandLiuL-W2010Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed byLactococcus lactisinduces specific antibody production. J Biomed Biotech201019
  45. 45. LianW-HHsiaoH-CandChouC-C2003Viability of microencapsulated bifidobacteria in simulated gastric juice and bile solution.Int J Food Microbiol86293301
  46. 46. LindholmASmedsAandPalvaA2004Receptor binding domain ofEscherichia coliF18 fimbrial adhesin FedF can be both efficiently secreted and surface displayed in a functional form in Lactococcus lactis. Appl Environ Microbial7020612071
  47. 47. LiuJ-KHouX-LWeiC-HYuL-YHeX-JWangG-HLeeJ-SandKimC-J2009Induction of immune responses in mice after oral immunization with recombinantLactobacillus caseistrains expressing enterotoxigenic Escherichia coli F41 fimbrial protein. Appl Environ Microbiol7544914497
  48. 48. MaassenC. B. MLamanJ. DHeijne den bak-Glashouwer M. J., Tielen, F. J., van Holten-Neelen, J. C. P. A., Hoogteijling, L., Antonissen, C., Leer, R. J., Pouwels, P. H., Boersma, W. J. A. and Shaw, D. M. (1999Instruments for oral disease intervention strategies: recombinantLactobacillus caseiexpressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis. Vaccine1721172128
  49. 49. MckayL. LandBaldwinK. A1990Applications for biotechnology: present and future improvements in lactic acid bacteria.FEMS Microbiol Lett87314
  50. 50. MedinaMVillenaJVintiniEHebertE. MRayaRandAlvarezS2008Nasal immunization withLactococcus lactisexpressing the pnemococcal protective protein A induces protective immunity in mice. Infect Immun7626962705
  51. 51. MielcarekNAlonsoSandLochtC2001Nasal vaccination using live bacterial vectors. Adv Drug Deliv Rev515569
  52. 52. MooreR. JStewartD. JLundKandHodgsonL. M2001Vaccination against ovine footrot using a live bacterial vector to deliver basic protease antigen. FEMS Microbiol Lett194193196
  53. 53. MyllaerinenPForssellPVon,W. AAlanderMMattila-sandholmTandPoutanenK. (2001Starch capsules containing microorganisms and/or polypeptides or proteins and a process for producing them, In:European patentEP1063976, Available from: <>.
  54. 54. NaritaJOkanoKKitaoTIshidaSSewakiTSungM-HFukudaHandKondoA2006Display of α-amylase on the surface ofLactobacillus caseicells by use of the PgsA anchor protein, and production of lactic acid from starch. 2006. Appl Environ Microbiol72269275
  55. 55. NavarreW. WandSchneewindO1994Proteolytic cleavage and cell wall anchoring at the LPXTG motif of surface proteins in gram positive bacteria.Mol Microbiol14115121
  56. 56. NortonP. MBrownH. W. GWellsJ. MMacphersonA. MWilsonP. Wand Le Page, R. W. F. (1996Factors affecting the immunogenicity of tetanus toxin fragment C expressed inLactococcus lactis. FEMS Immunol Med Microbiol14167177
  57. 57. OlivieraM. L. SAreasA. P. MCamposI. BMonedroVPerez-martinezGMiyajiE. NLeiteL. C. CAiresK. AandHoP. L2006Induction of systemic and mucosal immune response and decrease inStreptococcus pneumoniaecolonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect810161024
  58. 58. OlveraCFernandez-vazquezJ. LLedezma-candanozaLandLopez-munguiaA2007Role of the C-terminal region of dextransucrase fromLeuconostoc mesentroidesIBT-PQ in cell anchoring. Microbiol15339944002
  59. 59. PiardJ. CHautefortIFischettiV. AEhrlichS. DFonsMandGrussA1997aCell wall anchoring ofStreptococcus pyogenesM6 protein in various lactic acid bacteria. J Bacteriol17930683072
  60. 60. PooHPyoH-MLeeT-YYoonS-WLeeJ-SKimC-JSungM-HandLeeS-H2006Oral administration of human papilomavirus type 16 E7 displayed onLactobacillus caseiinduces E7-specific antitumor effects in C57/BL6 mice. Int J Cancer11917021709
  61. 61. PoquetIDusko Ehrlich, S. and Gruss, A. (1998An export specific reporter designed for gram positive bacteria: application toLactococcus lactis. J Bacteriol18019041912
  62. 62. PouwelsP. HLeerR. JandBoersmaW. J. A1996The potential of Lactobacillus as a carrier for oral immunization: Development and preliminary characterization of vector systems for targeted delivery of antigens.J Biotechnol44183192
  63. 63. PouwelsP. HLeerR. JShawMden Bak-Glashouwer, M-J. H., Tielen, F. D., Smit, E., Martinez, B., Jore, J. and Conway, P. L. (1998Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol41155167
  64. 64. RamosH. CRumboMandSiradJ-C2004Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa.Trends Microbiol12509517
  65. 65. ShigechiHKohJFujitaYMatsumotoTBitoYUedaMSatohEFukudaHandKondoA2004Direct production of ethanol from raw corn starch via fermentation by use of a novel surface-engineered yeast strain codisplaying glucoamylase and α-amylase.Appl Environ Microbiol7050375040
  66. 66. SiezenRBoekhorestJMuscarielloLMolenaarDRenckensBKleerebezemM2006Lactobacillus plantarumgene clusters encoding putative cell surface protein complexes for carbohydrate utilization are conserved in specific gram positive bacteria. BMC Genomics 7, 126.
  67. 67. SiragusaSDe AngelisMDi Cagno, R., Rizzello, G., Coda, R. and Gobbetti, M. (2007Synthesis of γ-aminobutyric acid by lactic acid bacteria isolated from a variety of Italian cheeses.Appl Environ Microbiol7372837290
  68. 68. SmitEJagerDMartinezBTielenF. JandPouwelsP. H2002Structural and functional analysis of the S-layer protein crystallisation domain ofLactobacillus acidophilusATCC 4356: evidence for protein-protein interaction of two subdomains. J Mol Biol324953964
  69. 69. SteidlerLViaeneJFiersWandRemautE1998Functional display of a heterologous protein on the surface ofLactococcus lactisby mean of cell wall anchor of Staphylococcus aureus protein A. Appl Environ Microbiol64342345
  70. 70. StilesM. EandHolzapfelW. H1997Lactic acid bacteria of foods and their current taxonomy.Int J Food Microbiol36129
  71. 71. StorniTKundigT. MSentiGandJohansenP2005Immunity in response to particulate antigen delivery systems. Adv Drug Deliv Rev57333355
  72. 72. TangLandLiY2009Oral immunization of mice with recombinantLactococcus lactisexpressing porcine transmissible gastroenteritis virus spike glycoprotein. Virus Genes39238245
  73. 73. TarahomjooSKatakuraYSatohEandShioyaS2008aBidirectional cell-surface anchoring function of the C-terminal repeat region of peptidoglycan hydrolase ofLactococcus lactisIL1403. J Biosci Bioeng105116121
  74. 74. TarahomjooSKatakuraYandShioyaS2008bExpression of C-terminal repeat region of peptidoglycan hydrolase ofLactococcus lactisIL1403 in methylotrophic yeast Pichia pastoris. J Biosci Bioeng105134139
  75. 75. Toyota-hantaniYInoueMEkawaTOhtaHIgimiSandBabaE2008importance of the major FliC antigenic site ofSalmonella enteritidisas a subunit vaccine antigen. Vaccine2641354137
  76. 76. TurnerM. SandGiffardP. M1999Expression ofChlamydia psittaciand human immunodeficiency virus derived antigens on the cell surface of Lactobacillus fermentum BR11 as fusions to BspA. Infect Immun6754865489
  77. 77. TurnerM. SHafnerL. MWalshTandGiffardP2004Identification and characterization of the novel LysM domain containing surface protein Sep fromLactobacillus fermentumBR11 and its use as a peptide fusion partner in Lactobacillus and Lactococcus. Appl Environ Microbiol7036733680
  78. 78. Van Der VaartJ. MBiesebekeRChapmanJ. WToschkaH. YKlisF. MandVerripsT1997Comparison of cell wall proteins ofSaccharomyces cervisiaeas anchors for cell surface expression of heterologous proteins. Appl Environ Microbiol,63615620
  79. 79. VenemaRTjalsmaHVan DijlJ. MDe JongALeenhoutsKBuistGandVenemaG2003Active lipoprotein precursors in the gram positive eubacteriumLactococcus lactis. J Biol Chem2781473914746
  80. 80. WanH-MChangB-YandLinS-C2002Anchorage of cyclodextrin glucanotransferase on the outer membrane ofEscherichia coli. Biotechnol Bioeng79457464
  81. 81. WangXBrownI. LEvansA. JandConwayP. L1999The protective effect of high amylose maize (amylomaize) starch granules on the survival ofBifidobacteriumspp. in the mouse intestinal tract. J Appl Microbiol87631639
  82. 82. WeiC-HLiuJ-KHouX-LYuL-YLeeJ-SandKimC-J2010Immunogenicity and protective efficacy of orally or intranasally administered recombinantLactobacillus caseiexpressing ETEC K99. Vaccine2841134118
  83. 83. WellsJ. MRobinsonKChamberlainL. MSchofieldK. Mand Le Page, R. W. F. (1996Lactic acid bacteria as vaccine delivery vehicles.Antonie van Leeuwen70317330
  84. 84. WesterlundBandKorhonenT. K1993Bacterial proteins binding to the mammalian extracellular matrix.Mol Microbiol9687694
  85. 85. WieczorekAandMartinV. J. J2010Engineering the cell surface display of cohesions for assembly of cellulosome inspired enzyme complexes onLactococcus lactis. Microbial Cell Fact 9, 69.
  86. 86. XinK-QHoshinoYTodaYIgimiSKojimaYJounaiNOhbaKKushiroAKiwakiMHamajimaKKlinmanDandOkudaK2003Immunogenicity and protective efficacy of orally administered recombinantLactococcus lactisexpressing surface-bound HIV Env. Blood102223228
  87. 87. XuWHuangMZhangYYiXDongWGaoXandJiaC2011Novel surface display system for heterogonous proteins onLactobacillus plantarum. Lett Appl Microbiol53641648
  88. 88. YamaguchiKFujioYandInouyeM1988A single amino acid determinant of the membrane localization of lipoproteins inE. coli. Cell53423432

Written By

Shirin Tarahomjoo

Submitted: November 16th, 2011 Reviewed: June 18th, 2012 Published: January 30th, 2013